Iron Infusion Guidelines for Iron Deficiency

Diagnostic Criteria and Indications

A transferrin saturation (TSAT) of less than 20% is the established cutoff for identifying iron deficiency in chronic kidney disease (CKD), cancer-related anemia, and general iron deficiency states, as recommended by the American Journal of Kidney Diseases 1, 2
The American Journal of Kidney Diseases suggests that absolute iron deficiency is defined as TSAT <20% combined with ferritin <100 ng/mL in CKD patients 1
The American Journal of Hematology recommends IV iron therapy when TSAT <20% in cancer patients with anemia 3, 4
For patients with end-stage renal disease and restless legs syndrome, IV iron is suggested when TSAT <20% (combined with ferritin <200 ng/mL), according to the Journal of Clinical Sleep Medicine 5

The American Journal of Hematology recommends preferred formulations, including ferric carboxymaltose (1000 mg single dose over 15 minutes), iron isomaltoside, or ferumoxytol for convenience 6
Alternative regimens include iron sucrose (100 mg weekly) or ferric gluconate (125 mg weekly) for 8-10 doses, as suggested by the American Journal of Hematology 3

TSAT typically increases by 6-11% from baseline after IV iron administration, according to the American Journal of Hematology 3, 4
Ferritin will increase substantially (mean increases of 200-400 ng/mL reported in studies) after IV iron administration, as reported by the American Journal of Hematology 3, 4

If ferritin is 100-700 ng/mL with TSAT <20%, a trial of weekly IV iron (50-125 mg) for 8-10 doses is recommended by the American Journal of Kidney Diseases 1, 2
Hold IV iron if TSAT rises above 50% during treatment, as recommended by the American Journal of Hematology 3, 4
Hold IV iron if ferritin exceeds 1000 ng/mL in most contexts, according to the American Journal of Hematology 3, 4
For dialysis patients, the upper ferritin limit is 500 ng/mL per KDIGO guidelines, as recommended by the journal Drugs 6

Iron infusions are indicated when patients cannot tolerate oral iron supplements, such as those with impaired absorption due to bariatric surgery or active inflammatory bowel disease 7
Iron infusions are also indicated when blood counts or iron stores do not improve with oral iron supplementation, or when iron loss exceeds absorption capacity of oral iron 8

Serious adverse reactions to IV iron are very rare, occurring in approximately 1:250,000 administrations with modern formulations 7
Most reactions are complement activation-related pseudo-allergies that can mimic allergic reactions rather than true allergies, and can be managed by stopping the infusion and restarting at a slower rate 8
Hemoglobin levels should increase by approximately 1 g/dL within 2 weeks of supplementation, and basic blood tests should be repeated after 8-10 weeks to measure the success of treatment 8, 7

Several different formulations of IV iron are available with different dosing schedules, including iron carboxymaltose, iron sucrose, and ferric gluconate 8, 7
Formulations that can replace iron deficits with 1-2 infusions are generally preferred, such as iron carboxymaltose, which can be administered as a single dose of 1g over 15 minutes 8, 7

The efficacy of IV iron is not affected by food intake prior to administration, and there are no dietary restrictions or fasting requirements before iron infusions 8, 9, 7
Patient comfort should be considered, and having a light meal before the procedure may help prevent lightheadedness during the infusion, although this is not a formal recommendation 7